Published in Open Virol J on June 14, 2012
Attenuation of green fluorescent protein half-life in mammalian cells. Protein Eng (1999) 3.65
The synthesis of sendai virus polypeptides in infected cells. Virology (1976) 3.26
Complexes of Sendai virus NP-P and P-L proteins are required for defective interfering particle genome replication in vitro. J Virol (1992) 2.73
The paramyxovirus, Sendai virus, V protein encodes a luxury function required for viral pathogenesis. EMBO J (1997) 2.71
A stuttering model for paramyxovirus P mRNA editing. EMBO J (1990) 2.30
Nonsegmented negative-strand RNA virus RNA synthesis in vivo. Virology (2008) 2.13
An N-terminal domain of the Sendai paramyxovirus P protein acts as a chaperone for the NP protein during the nascent chain assembly step of genome replication. J Virol (1995) 1.98
Efficient gene transfer to airway epithelium using recombinant Sendai virus. Nat Biotechnol (2000) 1.71
Sendai virus Y proteins are initiated by a ribosomal shunt. Mol Cell Biol (1998) 1.63
Normal cellular replication of Sendai virus without the trans-frame, nonstructural V protein. Virology (1997) 1.62
The hypervariable C-terminal tail of the Sendai paramyxovirus nucleocapsid protein is required for template function but not for RNA encapsidation. J Virol (1993) 1.61
An acidic activation-like domain of the Sendai virus P protein is required for RNA synthesis and encapsidation. Virology (1994) 1.51
Accumulated measles virus mutations in a case of subacute sclerosing panencephalitis: interrupted matrix protein reading frame and transcription alteration. Virology (1986) 1.49
Deletion analysis defines a carboxyl-proximal region of Sendai virus P protein that binds to the polymerase L protein. Virology (1994) 1.44
Dynamics of viral RNA synthesis during measles virus infection. J Virol (2005) 1.44
The Sendai virus V protein interacts with the NP protein to regulate viral genome RNA replication. Virology (1996) 1.40
Sendai virus gene expression in lytically and persistently infected cells. Virology (1990) 1.24
Reexamination of the Sendai virus P protein domains required for RNA synthesis: a possible supplemental role for the P protein. Virology (1996) 1.23
Regulatory events in the synthesis of Sendai virus polypeptides and their assembly into virions. Virology (1976) 1.11
Localization of P, NP, and M proteins on Sendai virus nucleocapsid using immunogold labeling. Virology (1986) 1.11
Intracellular stability of nonreplicating paramyxovirus nucleocapsids. Virology (1990) 1.05
Long-term replication of Sendai virus defective interfering particle nucleocapsids in stable helper cell lines. J Virol (1994) 1.02
Sendai virus-based expression of HIV-1 gp120: reinforcement by the V(-) version. Genes Cells (1997) 1.01
Rapid and efficient recovery of Sendai virus from cDNA: factors influencing recombinant virus rescue. J Virol Methods (1998) 0.94
De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol (2007) 0.91
Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res (2004) 0.85
Quantitative proteomics reveals subset-specific viral recognition in dendritic cells. Immunity (2010) 4.03
Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis (2004) 1.30
Overcoming lability of extremely long alkane carbon-carbon bonds through dispersion forces. Nature (2011) 1.29
Depletion of T-cell receptor alpha/beta and CD19 positive cells from apheresis products with the CliniMACS device. Cytotherapy (2013) 1.23
TaqMan-based quantification of invasive cells in the chick embryo metastasis assay. Biotechniques (2004) 1.23
Feasibility and outcome of reduced-intensity conditioning in haploidentical transplantation. Ann N Y Acad Sci (2007) 1.05
Transplantation of CD3/CD19 depleted allografts from haploidentical family donors in paediatric leukaemia. Br J Haematol (2014) 1.05
Inhibition of influenza virus infection by multivalent sialic-acid-functionalized gold nanoparticles. Small (2010) 1.05
Reconstitution of an apicoplast-localised electron transfer pathway involved in the isoprenoid biosynthesis of Plasmodium falciparum. FEBS Lett (2005) 1.00
Induction of neutralising antibodies and cellular immune responses against SARS coronavirus by recombinant measles viruses. Vaccine (2008) 0.98
High proportion of leukemic stem cells at diagnosis is correlated with unfavorable prognosis in childhood acute myeloid leukemia. Pediatr Hematol Oncol (2011) 0.97
Chimeric CD19 antibody mediates cytotoxic activity against leukemic blasts with effector cells from pediatric patients who received T-cell-depleted allografts. Blood (2004) 0.96
Different substitutions at conserved amino acids in domains II and III in the Sendai L RNA polymerase protein inactivate viral RNA synthesis. Virology (2002) 0.96
Recombinant measles viruses expressing single or multiple antigens of human immunodeficiency virus (HIV-1) induce cellular and humoral immune responses. Vaccine (2009) 0.95
Selective induction of apoptosis in leukemic B-lymphoid cells by a CD19-specific TRAIL fusion protein. Cancer Immunol Immunother (2007) 0.95
The bifunctional flavokinase/flavin adenine dinucleotide synthetase from Streptomyces davawensis produces inactive flavin cofactors and is not involved in resistance to the antibiotic roseoflavin. J Bacteriol (2007) 0.95
Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16). Br J Haematol (2005) 0.93
Retransplantation with stem cells from mismatched related donors after graft rejection in pediatric patients. Blood Cells Mol Dis (2007) 0.93
Caspase-8 and Apaf-1-independent caspase-9 activation in Sendai virus-infected cells. J Biol Chem (2002) 0.92
Inhibition of selectin binding by colloidal gold with functionalized shells. Chem Commun (Camb) (2009) 0.92
De novo synthesis of N and P proteins as a key step in Sendai virus gene expression. J Virol (2007) 0.91
Sendai virus vectors as an emerging negative-strand RNA viral vector system. J Gene Med (2003) 0.91
Negative-strand RNA viral vectors: intravenous application of Sendai virus vectors for the systemic delivery of therapeutic genes. Mol Ther (2003) 0.87
Multivalent interaction and selectivities in selectin binding of functionalized gold colloids decorated with carbohydrate mimetics. Org Biomol Chem (2011) 0.86
Efficient propagation of single gene deleted recombinant Sendai virus vectors. Virus Res (2004) 0.85
"Four birds with one stone": synthesis of nanostructures of ZnTe, Te, ZnAl2O4, and Te/ZnAl2O4 from a single-source precursor. Angew Chem Int Ed Engl (2006) 0.85
Recombinant Sendai virus induces T cell immunity against respiratory syncytial virus that is protective in the absence of antibodies. Cell Immunol (2007) 0.85
Long-term IL-2 therapy after transplantation of T cell depleted stem cells from alternative donors in children. Best Pract Res Clin Haematol (2011) 0.83
A chimeric respiratory syncytial virus fusion protein functionally replaces the F and HN glycoproteins in recombinant Sendai virus. J Virol (2005) 0.82
Natural killer cell activity influences outcome after T cell depleted stem cell transplantation from matched unrelated and haploidentical donors. Best Pract Res Clin Haematol (2011) 0.81
Influence of variable N-glycosylation on the cytolytic potential of chimeric CD19 antibodies. J Immunother (2006) 0.81
Sendai virus trailer RNA simultaneously blocks two apoptosis-inducing mechanisms in a cell type-dependent manner. J Gen Virol (2005) 0.80
Switchable electrostatic interactions between gold nanoparticles and coiled coil peptides direct colloid assembly. Org Biomol Chem (2008) 0.80
Sequence and immunogenicity of a clinically approved novel measles virus vaccine vector. Hum Vaccin Immunother (2013) 0.80
Nanoparticle-induced folding and fibril formation of coiled-coil-based model peptides. Small (2010) 0.79
Cell cycle independent infection and gene transfer by recombinant Sendai viruses. J Virol Methods (2003) 0.79
Establishment of a rhabdomyosarcoma xenograft model in human-adapted mice. Oncol Rep (2010) 0.78
Di(benzothiazol-2-yl)phosphanide as a Janus-head ligand to caesium. Chemistry (2007) 0.78
Synthesis of tumor-associated MUC1-glycopeptides and their multivalent presentation by functionalized gold colloids. Org Biomol Chem (2015) 0.77
Recombinant Sendai virus for efficient gene transfer to human airway epithelium. Exp Lung Res (2004) 0.77
Severe impairment of dendritic cell allostimulatory activity by Sendai virus vectors is overcome by matrix protein gene deletion. J Immunol (2005) 0.77
Molecular detection of measles virus in primary cell cultures of otosclerotic tissue. Acta Otolaryngol (2006) 0.76
Siglec-7 tetramers characterize B-cell subpopulations and leukemic blasts. Eur J Immunol (2012) 0.76
Evaluation of a novel immunogenic vaccine platform based on a genome replication-deficient Sendai vector. Vaccine (2013) 0.76
Effects of multivalent histamine supported on gold nanoparticles: activation of histamine receptors by derivatized histamine at subnanomolar concentrations. Org Biomol Chem (2015) 0.75
Adsorption behavior of 4-methoxypyridine on gold nanoparticles. Langmuir (2011) 0.75
Stabilization of the thermodynamically favored polymorph of cadmium chalcogenide nanoparticles CdX (X = S, Se, Te) in the polar mesopores of SBA-15 silica. Inorg Chem (2005) 0.75
Low-temperature formation of cubic β-PbF2: precursor-based synthesis and first-principles phase stability study. Phys Chem Chem Phys (2011) 0.75
Porous silicon and alumina as chemically reactive templates for the synthesis of tubes and wires of SnSe, Sn, and SnO2. Angew Chem Int Ed Engl (2005) 0.75
Nanostructured composites of Bi1-xSbx nanoparticles and carbon nanotubes and the characterization of their thermoelectric properties. ACS Appl Mater Interfaces (2017) 0.75
Thin-walled Er3+:Y2O3 nanotubes showing up-converted fluorescence. Phys Chem Chem Phys (2009) 0.75
Polymer-assisted preparation of nanoscale films of thermoelectric PbSe and PbTe and of lead chalcogenide-polymer composite films. Dalton Trans (2010) 0.75
Metal-enhanced luminescence in colloidal solutions of CdSe and metal nanoparticles: investigation of density dependence and optical band overlap. Phys Chem Chem Phys (2015) 0.75